{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0068-0597#drug","name":"Rifadin IV","alternateName":"rifampin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0068-0597"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA050627"},{"@type":"PropertyValue","propertyID":"UNII","value":"VJT6J7R4TR"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"036ab68e-5085-4edc-bd83-784b43d64eab"}],"activeIngredient":"RIFAMPIN","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Sanofi-Aventis U.S. LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA050627","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0068-0597"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T04:54:37.655Z"}}